Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide

Although many treatments have been applied to treat hormone-refractory prostate cancer (HRPC), therapeutic outcome is not altogether satisfactory. In the case of locally recurring HRPC, uncontrolled gross hematuria, dysuria, and scalding are often experienced. We report a patient who improved follow...

Descripción completa

Detalles Bibliográficos
Autores principales: Uemura, Keiichiro, Nishihara, Kiyoaki, Hayashi, Tokumasa, Tomiyasu, Katsuro, Matsuoka, Kei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491188/
https://www.ncbi.nlm.nih.gov/pubmed/22203121
http://dx.doi.org/10.1007/s10156-011-0352-9
_version_ 1782248942733361152
author Uemura, Keiichiro
Nishihara, Kiyoaki
Hayashi, Tokumasa
Tomiyasu, Katsuro
Matsuoka, Kei
author_facet Uemura, Keiichiro
Nishihara, Kiyoaki
Hayashi, Tokumasa
Tomiyasu, Katsuro
Matsuoka, Kei
author_sort Uemura, Keiichiro
collection PubMed
description Although many treatments have been applied to treat hormone-refractory prostate cancer (HRPC), therapeutic outcome is not altogether satisfactory. In the case of locally recurring HRPC, uncontrolled gross hematuria, dysuria, and scalding are often experienced. We report a patient who improved following intra-arterial infusion of cisplatin (CDDP) and ifosfamide (IFM) to treat urinary retention caused by locally recurring HRPC. After chemotherapy, cancer volume was remarkably reduced and symptoms improved.
format Online
Article
Text
id pubmed-3491188
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-34911882012-11-08 Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide Uemura, Keiichiro Nishihara, Kiyoaki Hayashi, Tokumasa Tomiyasu, Katsuro Matsuoka, Kei J Infect Chemother Case Report Although many treatments have been applied to treat hormone-refractory prostate cancer (HRPC), therapeutic outcome is not altogether satisfactory. In the case of locally recurring HRPC, uncontrolled gross hematuria, dysuria, and scalding are often experienced. We report a patient who improved following intra-arterial infusion of cisplatin (CDDP) and ifosfamide (IFM) to treat urinary retention caused by locally recurring HRPC. After chemotherapy, cancer volume was remarkably reduced and symptoms improved. Springer Japan 2011-12-28 2012-10 /pmc/articles/PMC3491188/ /pubmed/22203121 http://dx.doi.org/10.1007/s10156-011-0352-9 Text en © Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases 2011
spellingShingle Case Report
Uemura, Keiichiro
Nishihara, Kiyoaki
Hayashi, Tokumasa
Tomiyasu, Katsuro
Matsuoka, Kei
Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide
title Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide
title_full Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide
title_fullStr Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide
title_full_unstemmed Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide
title_short Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide
title_sort improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491188/
https://www.ncbi.nlm.nih.gov/pubmed/22203121
http://dx.doi.org/10.1007/s10156-011-0352-9
work_keys_str_mv AT uemurakeiichiro improvementinurinaryretentionduetorecurrentanastomoticprostatecancertreatedwithvarioustherapiesbyintraarterialinfusionofcisplatinandifosfamide
AT nishiharakiyoaki improvementinurinaryretentionduetorecurrentanastomoticprostatecancertreatedwithvarioustherapiesbyintraarterialinfusionofcisplatinandifosfamide
AT hayashitokumasa improvementinurinaryretentionduetorecurrentanastomoticprostatecancertreatedwithvarioustherapiesbyintraarterialinfusionofcisplatinandifosfamide
AT tomiyasukatsuro improvementinurinaryretentionduetorecurrentanastomoticprostatecancertreatedwithvarioustherapiesbyintraarterialinfusionofcisplatinandifosfamide
AT matsuokakei improvementinurinaryretentionduetorecurrentanastomoticprostatecancertreatedwithvarioustherapiesbyintraarterialinfusionofcisplatinandifosfamide

Ejemplares similares